Healthcare -
Biotechnology - NASDAQ - US
$ 358.93
-2.04 %
$ 16 B
Market Cap
15.78
P/E
UTHR - INTEREST INCOME & EXPENSE
Interest Income & Expense UTHR - United Therapeutics Corporation
59.3 M
LAST VALUE
78.55%
2 YEAR CAGR
33.66%
5 YEAR CAGR
12.63%
10 YEAR CAGR